In previous studies, the prognostic value of CD25 protein expression in favorable-risk AML or CBF AML has not been reported probably due to the low frequency of CD25 positive cases in favorable-risk group in the cohorts [5, 7]. The gene discussed is IL2RA; the disease is acute myeloid leukemia.